Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedRemoved the 'Ovarian Cancer' topic tag and related topics such as MedlinePlus Genetics from the study page. This affects the page’s categorization and discoverability for users searching by disease.SummaryDifference0.2%

- Check11 days agoChange DetectedThe page shows a minor revision update from v3.2.0 to v3.3.2 with no observable changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedRemoved the government funding/operating status notice banner from the page.SummaryDifference0.4%

- Check32 days agoChange DetectedNo additions or deletions were detected; the Study Details page content appears unchanged.SummaryDifference0.4%

- Check46 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Ovarian cancer, expanding the page's coverage to include genetic information about ovarian cancer.SummaryDifference0.2%

- Check61 days agoChange DetectedAdd: new government funding/status notice and v3.2.0; Remove: old ovarian cancer topic listing and v3.1.0.SummaryDifference3%

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.